-
Select a region
-
Select language
Select language
Xevoben, Levodopum + Benserazidum, 50 mg + 12,5 mg
Xevoben, Levodopum + Benserazidum, 100 mg + 25 mg
Xevoben, Levodopum + Benserazidum, 200 mg + 50 mg
Xevoben XR, Levodopum + Benserazidum, 100 mg + 25 mg
| Form: Tablets/Capsules | Size: 100 Tablets/100 capsules |
Oral use 
Xevoben is contraindicated for use in children, adolescents and patients under 25 years of age Xevoben is used:
– in the treatment of Parkinson’s disease (shaking palsy, a disease characterised by coarse tremors, slowed movements and muscular rigidity);
– in the treatment of symptoms that resemble those of Parkinson’s disease, but are the result of intoxication, encephalitis and brain alterations due to arteriosclerosis (symptomatic parkinsonian syndromes). Exceptions are Parkinson’s-like symptoms triggered by certain medicines (drug-induced parkinsonian syndrome).
